Lucas Tien Wee Luk - Chief Clinical Officer, Director at CytoMed Therapeutics Ltd

Issuer-level insider activity

Role
Chief Clinical Officer, Director
Issuer ticker
GDTC on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Lucas Tien Wee Luk since 13 Aug 2025

Reported holdings for Lucas Tien Wee Luk in CytoMed Therapeutics Ltd

Form 4 holding Chief Clinical Officer, Director

CytoMed Therapeutics Ltd

Security class
Ordinary Shares, no par value per share
Shares / value
92,563
Estimated value
Report date
31 Mar 2023
Price
Ownership
Direct

Transaction history for Lucas Tien Wee Luk in CytoMed Therapeutics Ltd

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .